Chiusura precedente | 6,11 |
Aperto | 6,06 |
Denaro | 0,00 x 0 |
Lettera | 6,45 x 100 |
Min-Max giorno | 6,06 - 6,57 |
Intervallo di 52 settimane | 3,72 - 8,69 |
Volume | |
Media Volume | 35.885 |
Capitalizzazione | 84,546M |
Beta (5 anni mensile) | N/D |
Rapporto PE (ttm) | 27,38 |
EPS (ttm) | 0,24 |
Prossima data utili | 02 mag 2024 |
Rendimento e dividendo (futuro) | 0,16 (2,44%) |
Data ex dividendo | 29 feb 2024 |
Stima target 1A | N/D |
The presentation can be viewed by scanning the QR code The presentation can be viewed by scanning the QR code Highlights Decisive Actions Taken by Board to Rebuild Senior Leadership Team and Develop New LV360 Strategy That Is Delivering Results Urges Stockholders to Vote “FOR” LifeVantage’s Seven Highly Engaged Directors on the WHITE Universal Proxy Card SALT LAKE CITY, Oct. 16, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company,”), a leading health an
Convention hosted in San Antonio, TX, October 5-7, attended by over 2,000 Independent Consultants from around the worldSALT LAKE CITY, Oct. 09, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today announced the successful conclusion of their annual Global Convention, held from October 5-7, 2023, in San Antonio, TX. Over 2,000 LifeVantage Consultants
Send Letter to Stockholders Detailing the Value Delivered by the Targeted DirectorsSALT LAKE CITY, Oct. 05, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today publicized a letter written by four of its directors who are not being targeted by activist stockholder Radoff-Sudbury Group. In the letter, the directors express their support for the targ